Company Filing History:
1 out of 775 
1 out of 3 Years Active: 2012
Title: Innovations in Diabetes Management: The Contributions of Kathleen Dungan
Introduction
Kathleen Dungan is a notable inventor based in Columbus, OH, who has made significant contributions to the field of diabetes management. Her innovative approach focuses on improving the estimation of blood glucose excursions in diabetic patients, which is crucial for effective disease management.
Latest Patents
Dungan holds a patent for a method of estimation of blood glucose excursions in diabetic patients using the 1,5-anhydroglucitol (1,5-AG) assay. This invention provides a method for measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular. The 1,5-AG levels and percent changes in these levels over a short period are indicative of differing post-meal glucose levels in moderately-controlled diabetic patients with similar A1C levels. This assay is particularly useful for identifying diabetic patients who may be at risk for cardiovascular complications that would not be identifiable by A1C levels alone. Furthermore, the ratios of A1C divided by 1,5-AG in each patient serve as superior indicators compared to 1,5-AG levels alone.
Career Highlights
Throughout her career, Kathleen Dungan has worked with reputable companies such as Nippon Kayaku and Toyota Tsusho America, Inc. Her experience in these organizations has contributed to her expertise in diabetes research and innovation.
Collaborations
Dungan has collaborated with esteemed colleagues in her field, including John Bernard Buse and Steven D Wittlin. These collaborations have further enhanced her research and development efforts in diabetes management.
Conclusion
Kathleen Dungan's innovative work in diabetes management through her patented methods demonstrates her commitment to improving patient care. Her contributions are vital in the ongoing fight against diabetes and its complications.